Page last updated: 2024-08-22

actinium and Multiple Myeloma

actinium has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Breckpot, K; Bruchertseifer, F; D'Huyvetter, M; De Veirman, K; Devoogdt, N; Ertveldt, T; Goyvaert, C; Hanssens, H; Hose, D; Krasniqi, A; Morgenstern, A; Muyldermans, S; Puttemans, J; Romao, E; Vlummens, P	1

Other Studies

1 other study(ies) available for actinium and Multiple Myeloma

Article	Year
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma. Oncoimmunology, 2021, Volume: 10, Issue:1 Topics: Actinium; Animals; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Humans; Mice; Multiple Myeloma; Signaling Lymphocytic Activation Molecule Family; Single-Domain Antibodies; Tissue Distribution; Xenograft Model Antitumor Assays	2021

Article

Year

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma.

Oncoimmunology, 2021, Volume: 10, Issue:1

Topics: Actinium; Animals; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Humans; Mice; Multiple Myeloma; Signaling Lymphocytic Activation Molecule Family; Single-Domain Antibodies; Tissue Distribution; Xenograft Model Antitumor Assays

2021